Sensei Biotherapeutics, Inc.

SNSE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$30-$34-$49-$37
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$4$6$6
Change in WC-$0-$4$1$0
Other Non-Cash$2$1$1$0
Operating Cash Flow-$25-$32-$39-$30
Investing Activities
PP&E Inv.-$0-$0-$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$45-$21-$47-$184
Inv. Sales/Matur.$67$60$97$42
Other Inv. Act.$0$0$0$0
Investing Cash Flow$22$38$50-$143
Financing Activities
Debt Repay.-$1-$1-$1-$0
Stock Issued$0$0$0$141
Stock Repurch.$0-$10$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$24
Financing Cash Flow-$1-$11-$0$164
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$5$11-$9
Supplemental Information
Beg. Cash$13$18$7$17
End Cash$10$13$18$7
Free Cash Flow-$25-$32-$39-$32